nodes	percent_of_prediction	percent_of_DWPC	metapath
Formoterol—Gastrointestinal pain—Thiotepa—sarcoma	0.0019	0.0019	CcSEcCtD
Formoterol—Ill-defined disorder—Etoposide—sarcoma	0.0019	0.0019	CcSEcCtD
Formoterol—Gastrointestinal pain—Dactinomycin—sarcoma	0.00189	0.00189	CcSEcCtD
Formoterol—Musculoskeletal discomfort—Vincristine—sarcoma	0.00188	0.00188	CcSEcCtD
Formoterol—Hypotension—Mitoxantrone—sarcoma	0.00188	0.00188	CcSEcCtD
Formoterol—Insomnia—Vincristine—sarcoma	0.00187	0.00187	CcSEcCtD
Formoterol—Urticaria—Thiotepa—sarcoma	0.00185	0.00185	CcSEcCtD
Formoterol—Malaise—Etoposide—sarcoma	0.00185	0.00185	CcSEcCtD
Formoterol—Abdominal pain—Thiotepa—sarcoma	0.00184	0.00184	CcSEcCtD
Formoterol—Body temperature increased—Thiotepa—sarcoma	0.00184	0.00184	CcSEcCtD
Formoterol—Musculoskeletal discomfort—Mitoxantrone—sarcoma	0.00183	0.00183	CcSEcCtD
Formoterol—Body temperature increased—Dactinomycin—sarcoma	0.00183	0.00183	CcSEcCtD
Formoterol—Abdominal pain—Dactinomycin—sarcoma	0.00183	0.00183	CcSEcCtD
Formoterol—Hypoglycaemia—Doxorubicin—sarcoma	0.00181	0.00181	CcSEcCtD
Formoterol—Dyspnoea—Mitoxantrone—sarcoma	0.00179	0.00179	CcSEcCtD
Formoterol—Cough—Etoposide—sarcoma	0.00179	0.00179	CcSEcCtD
Formoterol—Somnolence—Mitoxantrone—sarcoma	0.00179	0.00179	CcSEcCtD
Formoterol—Gastrointestinal disorder—Vincristine—sarcoma	0.00178	0.00178	CcSEcCtD
Formoterol—Fatigue—Vincristine—sarcoma	0.00178	0.00178	CcSEcCtD
Formoterol—Dehydration—Epirubicin—sarcoma	0.00177	0.00177	CcSEcCtD
Formoterol—Dyspepsia—Mitoxantrone—sarcoma	0.00177	0.00177	CcSEcCtD
Formoterol—Hypertension—Etoposide—sarcoma	0.00177	0.00177	CcSEcCtD
Formoterol—Pain—Vincristine—sarcoma	0.00177	0.00177	CcSEcCtD
Formoterol—Constipation—Vincristine—sarcoma	0.00177	0.00177	CcSEcCtD
Formoterol—Dry skin—Epirubicin—sarcoma	0.00175	0.00175	CcSEcCtD
Formoterol—Chest pain—Etoposide—sarcoma	0.00174	0.00174	CcSEcCtD
Formoterol—Hypokalaemia—Epirubicin—sarcoma	0.00174	0.00174	CcSEcCtD
Formoterol—Fatigue—Mitoxantrone—sarcoma	0.00173	0.00173	CcSEcCtD
Formoterol—Unspecified disorder of skin and subcutaneous tissue—Etoposide—sarcoma	0.00173	0.00173	CcSEcCtD
Formoterol—Discomfort—Etoposide—sarcoma	0.00172	0.00172	CcSEcCtD
Formoterol—Pain—Mitoxantrone—sarcoma	0.00172	0.00172	CcSEcCtD
Formoterol—Constipation—Mitoxantrone—sarcoma	0.00172	0.00172	CcSEcCtD
Formoterol—Hypersensitivity—Thiotepa—sarcoma	0.00172	0.00172	CcSEcCtD
Formoterol—Nasopharyngitis—Epirubicin—sarcoma	0.00171	0.00171	CcSEcCtD
Formoterol—Hypersensitivity—Dactinomycin—sarcoma	0.0017	0.0017	CcSEcCtD
Formoterol—Gastrointestinal pain—Vincristine—sarcoma	0.00169	0.00169	CcSEcCtD
Formoterol—Gastritis—Epirubicin—sarcoma	0.00169	0.00169	CcSEcCtD
Formoterol—Anaphylactic shock—Etoposide—sarcoma	0.00167	0.00167	CcSEcCtD
Formoterol—Asthenia—Thiotepa—sarcoma	0.00167	0.00167	CcSEcCtD
Formoterol—Infection—Etoposide—sarcoma	0.00166	0.00166	CcSEcCtD
Formoterol—Asthenia—Dactinomycin—sarcoma	0.00166	0.00166	CcSEcCtD
Formoterol—Feeling abnormal—Mitoxantrone—sarcoma	0.00166	0.00166	CcSEcCtD
Formoterol—Influenza—Epirubicin—sarcoma	0.00165	0.00165	CcSEcCtD
Formoterol—Asthma—Epirubicin—sarcoma	0.00165	0.00165	CcSEcCtD
Formoterol—Pruritus—Thiotepa—sarcoma	0.00165	0.00165	CcSEcCtD
Formoterol—Gastrointestinal pain—Mitoxantrone—sarcoma	0.00164	0.00164	CcSEcCtD
Formoterol—Dehydration—Doxorubicin—sarcoma	0.00164	0.00164	CcSEcCtD
Formoterol—Tachycardia—Etoposide—sarcoma	0.00163	0.00163	CcSEcCtD
Formoterol—Abdominal pain—Vincristine—sarcoma	0.00163	0.00163	CcSEcCtD
Formoterol—Body temperature increased—Vincristine—sarcoma	0.00163	0.00163	CcSEcCtD
Formoterol—Skin disorder—Etoposide—sarcoma	0.00162	0.00162	CcSEcCtD
Formoterol—Dry skin—Doxorubicin—sarcoma	0.00162	0.00162	CcSEcCtD
Formoterol—Hypokalaemia—Doxorubicin—sarcoma	0.00161	0.00161	CcSEcCtD
Formoterol—Angina pectoris—Epirubicin—sarcoma	0.00161	0.00161	CcSEcCtD
Formoterol—Urticaria—Mitoxantrone—sarcoma	0.0016	0.0016	CcSEcCtD
Formoterol—Diarrhoea—Thiotepa—sarcoma	0.00159	0.00159	CcSEcCtD
Formoterol—Body temperature increased—Mitoxantrone—sarcoma	0.00159	0.00159	CcSEcCtD
Formoterol—Abdominal pain—Mitoxantrone—sarcoma	0.00159	0.00159	CcSEcCtD
Formoterol—Bronchitis—Epirubicin—sarcoma	0.00159	0.00159	CcSEcCtD
Formoterol—Diarrhoea—Dactinomycin—sarcoma	0.00158	0.00158	CcSEcCtD
Formoterol—Nasopharyngitis—Doxorubicin—sarcoma	0.00158	0.00158	CcSEcCtD
Formoterol—Hypotension—Etoposide—sarcoma	0.00156	0.00156	CcSEcCtD
Formoterol—Gastritis—Doxorubicin—sarcoma	0.00156	0.00156	CcSEcCtD
Formoterol—Dizziness—Thiotepa—sarcoma	0.00154	0.00154	CcSEcCtD
Formoterol—Upper respiratory tract infection—Epirubicin—sarcoma	0.00153	0.00153	CcSEcCtD
Formoterol—Asthma—Doxorubicin—sarcoma	0.00153	0.00153	CcSEcCtD
Formoterol—Influenza—Doxorubicin—sarcoma	0.00153	0.00153	CcSEcCtD
Formoterol—Hypersensitivity—Vincristine—sarcoma	0.00152	0.00152	CcSEcCtD
Formoterol—Dyspnoea—Etoposide—sarcoma	0.00149	0.00149	CcSEcCtD
Formoterol—Hyperglycaemia—Epirubicin—sarcoma	0.00149	0.00149	CcSEcCtD
Formoterol—Somnolence—Etoposide—sarcoma	0.00149	0.00149	CcSEcCtD
Formoterol—Angina pectoris—Doxorubicin—sarcoma	0.00149	0.00149	CcSEcCtD
Formoterol—Hypersensitivity—Mitoxantrone—sarcoma	0.00148	0.00148	CcSEcCtD
Formoterol—Asthenia—Vincristine—sarcoma	0.00148	0.00148	CcSEcCtD
Formoterol—Vomiting—Thiotepa—sarcoma	0.00148	0.00148	CcSEcCtD
Formoterol—Vomiting—Dactinomycin—sarcoma	0.00147	0.00147	CcSEcCtD
Formoterol—Rash—Thiotepa—sarcoma	0.00147	0.00147	CcSEcCtD
Formoterol—Bronchitis—Doxorubicin—sarcoma	0.00147	0.00147	CcSEcCtD
Formoterol—Dermatitis—Thiotepa—sarcoma	0.00147	0.00147	CcSEcCtD
Formoterol—Headache—Thiotepa—sarcoma	0.00146	0.00146	CcSEcCtD
Formoterol—Rash—Dactinomycin—sarcoma	0.00146	0.00146	CcSEcCtD
Formoterol—Gastrointestinal disorder—Etoposide—sarcoma	0.00144	0.00144	CcSEcCtD
Formoterol—Asthenia—Mitoxantrone—sarcoma	0.00144	0.00144	CcSEcCtD
Formoterol—Fatigue—Etoposide—sarcoma	0.00144	0.00144	CcSEcCtD
Formoterol—Constipation—Etoposide—sarcoma	0.00143	0.00143	CcSEcCtD
Formoterol—Pain—Etoposide—sarcoma	0.00143	0.00143	CcSEcCtD
Formoterol—Conjunctivitis—Epirubicin—sarcoma	0.00143	0.00143	CcSEcCtD
Formoterol—Urinary tract infection—Epirubicin—sarcoma	0.00143	0.00143	CcSEcCtD
Formoterol—Upper respiratory tract infection—Doxorubicin—sarcoma	0.00142	0.00142	CcSEcCtD
Formoterol—Diarrhoea—Vincristine—sarcoma	0.00141	0.00141	CcSEcCtD
Formoterol—Haematuria—Epirubicin—sarcoma	0.0014	0.0014	CcSEcCtD
Formoterol—Nausea—Thiotepa—sarcoma	0.00138	0.00138	CcSEcCtD
Formoterol—Sinusitis—Epirubicin—sarcoma	0.00138	0.00138	CcSEcCtD
Formoterol—Feeling abnormal—Etoposide—sarcoma	0.00138	0.00138	CcSEcCtD
Formoterol—Hyperglycaemia—Doxorubicin—sarcoma	0.00138	0.00138	CcSEcCtD
Formoterol—Diarrhoea—Mitoxantrone—sarcoma	0.00138	0.00138	CcSEcCtD
Formoterol—Nausea—Dactinomycin—sarcoma	0.00137	0.00137	CcSEcCtD
Formoterol—Gastrointestinal pain—Etoposide—sarcoma	0.00137	0.00137	CcSEcCtD
Formoterol—Dizziness—Vincristine—sarcoma	0.00137	0.00137	CcSEcCtD
Formoterol—Urticaria—Etoposide—sarcoma	0.00133	0.00133	CcSEcCtD
Formoterol—Rhinitis—Epirubicin—sarcoma	0.00132	0.00132	CcSEcCtD
Formoterol—Abdominal pain—Etoposide—sarcoma	0.00132	0.00132	CcSEcCtD
Formoterol—Body temperature increased—Etoposide—sarcoma	0.00132	0.00132	CcSEcCtD
Formoterol—Urinary tract infection—Doxorubicin—sarcoma	0.00132	0.00132	CcSEcCtD
Formoterol—Conjunctivitis—Doxorubicin—sarcoma	0.00132	0.00132	CcSEcCtD
Formoterol—Vomiting—Vincristine—sarcoma	0.00131	0.00131	CcSEcCtD
Formoterol—Pharyngitis—Epirubicin—sarcoma	0.00131	0.00131	CcSEcCtD
Formoterol—Urinary tract disorder—Epirubicin—sarcoma	0.0013	0.0013	CcSEcCtD
Formoterol—Rash—Vincristine—sarcoma	0.0013	0.0013	CcSEcCtD
Formoterol—Dermatitis—Vincristine—sarcoma	0.0013	0.0013	CcSEcCtD
Formoterol—Oedema peripheral—Epirubicin—sarcoma	0.0013	0.0013	CcSEcCtD
Formoterol—Haematuria—Doxorubicin—sarcoma	0.0013	0.0013	CcSEcCtD
Formoterol—Connective tissue disorder—Epirubicin—sarcoma	0.0013	0.0013	CcSEcCtD
Formoterol—Urethral disorder—Epirubicin—sarcoma	0.00129	0.00129	CcSEcCtD
Formoterol—Headache—Vincristine—sarcoma	0.00129	0.00129	CcSEcCtD
Formoterol—Vomiting—Mitoxantrone—sarcoma	0.00128	0.00128	CcSEcCtD
Formoterol—Sinusitis—Doxorubicin—sarcoma	0.00128	0.00128	CcSEcCtD
Formoterol—Visual impairment—Epirubicin—sarcoma	0.00127	0.00127	CcSEcCtD
Formoterol—Rash—Mitoxantrone—sarcoma	0.00127	0.00127	CcSEcCtD
Formoterol—Dermatitis—Mitoxantrone—sarcoma	0.00127	0.00127	CcSEcCtD
Formoterol—Headache—Mitoxantrone—sarcoma	0.00126	0.00126	CcSEcCtD
Formoterol—Hypersensitivity—Etoposide—sarcoma	0.00123	0.00123	CcSEcCtD
Formoterol—Nausea—Vincristine—sarcoma	0.00123	0.00123	CcSEcCtD
Formoterol—Cardiac disorder—Epirubicin—sarcoma	0.00122	0.00122	CcSEcCtD
Formoterol—Rhinitis—Doxorubicin—sarcoma	0.00122	0.00122	CcSEcCtD
Formoterol—Pharyngitis—Doxorubicin—sarcoma	0.00121	0.00121	CcSEcCtD
Formoterol—Urinary tract disorder—Doxorubicin—sarcoma	0.00121	0.00121	CcSEcCtD
Formoterol—Oedema peripheral—Doxorubicin—sarcoma	0.0012	0.0012	CcSEcCtD
Formoterol—Asthenia—Etoposide—sarcoma	0.0012	0.0012	CcSEcCtD
Formoterol—Connective tissue disorder—Doxorubicin—sarcoma	0.0012	0.0012	CcSEcCtD
Formoterol—Urethral disorder—Doxorubicin—sarcoma	0.0012	0.0012	CcSEcCtD
Formoterol—Nausea—Mitoxantrone—sarcoma	0.00119	0.00119	CcSEcCtD
Formoterol—Immune system disorder—Epirubicin—sarcoma	0.00119	0.00119	CcSEcCtD
Formoterol—Mediastinal disorder—Epirubicin—sarcoma	0.00119	0.00119	CcSEcCtD
Formoterol—Pruritus—Etoposide—sarcoma	0.00118	0.00118	CcSEcCtD
Formoterol—Arrhythmia—Epirubicin—sarcoma	0.00118	0.00118	CcSEcCtD
Formoterol—Visual impairment—Doxorubicin—sarcoma	0.00118	0.00118	CcSEcCtD
Formoterol—Mental disorder—Epirubicin—sarcoma	0.00116	0.00116	CcSEcCtD
Formoterol—Malnutrition—Epirubicin—sarcoma	0.00115	0.00115	CcSEcCtD
Formoterol—Diarrhoea—Etoposide—sarcoma	0.00114	0.00114	CcSEcCtD
Formoterol—Cardiac disorder—Doxorubicin—sarcoma	0.00113	0.00113	CcSEcCtD
Formoterol—Tension—Epirubicin—sarcoma	0.00113	0.00113	CcSEcCtD
Formoterol—Dysgeusia—Epirubicin—sarcoma	0.00113	0.00113	CcSEcCtD
Formoterol—Nervousness—Epirubicin—sarcoma	0.00112	0.00112	CcSEcCtD
Formoterol—Back pain—Epirubicin—sarcoma	0.00111	0.00111	CcSEcCtD
Formoterol—Dizziness—Etoposide—sarcoma	0.00111	0.00111	CcSEcCtD
Formoterol—Muscle spasms—Epirubicin—sarcoma	0.0011	0.0011	CcSEcCtD
Formoterol—Immune system disorder—Doxorubicin—sarcoma	0.0011	0.0011	CcSEcCtD
Formoterol—Mediastinal disorder—Doxorubicin—sarcoma	0.0011	0.0011	CcSEcCtD
Formoterol—Arrhythmia—Doxorubicin—sarcoma	0.00109	0.00109	CcSEcCtD
Formoterol—Mental disorder—Doxorubicin—sarcoma	0.00107	0.00107	CcSEcCtD
Formoterol—Ill-defined disorder—Epirubicin—sarcoma	0.00107	0.00107	CcSEcCtD
Formoterol—Vomiting—Etoposide—sarcoma	0.00106	0.00106	CcSEcCtD
Formoterol—Malnutrition—Doxorubicin—sarcoma	0.00106	0.00106	CcSEcCtD
Formoterol—Agitation—Epirubicin—sarcoma	0.00106	0.00106	CcSEcCtD
Formoterol—Rash—Etoposide—sarcoma	0.00105	0.00105	CcSEcCtD
Formoterol—Dermatitis—Etoposide—sarcoma	0.00105	0.00105	CcSEcCtD
Formoterol—Headache—Etoposide—sarcoma	0.00105	0.00105	CcSEcCtD
Formoterol—Tension—Doxorubicin—sarcoma	0.00104	0.00104	CcSEcCtD
Formoterol—Dysgeusia—Doxorubicin—sarcoma	0.00104	0.00104	CcSEcCtD
Formoterol—Malaise—Epirubicin—sarcoma	0.00104	0.00104	CcSEcCtD
Formoterol—Nervousness—Doxorubicin—sarcoma	0.00103	0.00103	CcSEcCtD
Formoterol—Back pain—Doxorubicin—sarcoma	0.00103	0.00103	CcSEcCtD
Formoterol—Muscle spasms—Doxorubicin—sarcoma	0.00102	0.00102	CcSEcCtD
Formoterol—Palpitations—Epirubicin—sarcoma	0.00102	0.00102	CcSEcCtD
Formoterol—Cough—Epirubicin—sarcoma	0.001	0.001	CcSEcCtD
Formoterol—Nausea—Etoposide—sarcoma	0.000994	0.000994	CcSEcCtD
Formoterol—Hypertension—Epirubicin—sarcoma	0.000992	0.000992	CcSEcCtD
Formoterol—Ill-defined disorder—Doxorubicin—sarcoma	0.000986	0.000986	CcSEcCtD
Formoterol—Arthralgia—Epirubicin—sarcoma	0.000978	0.000978	CcSEcCtD
Formoterol—Chest pain—Epirubicin—sarcoma	0.000978	0.000978	CcSEcCtD
Formoterol—Myalgia—Epirubicin—sarcoma	0.000978	0.000978	CcSEcCtD
Formoterol—Agitation—Doxorubicin—sarcoma	0.000977	0.000977	CcSEcCtD
Formoterol—Anxiety—Epirubicin—sarcoma	0.000975	0.000975	CcSEcCtD
Formoterol—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—sarcoma	0.000971	0.000971	CcSEcCtD
Formoterol—Discomfort—Epirubicin—sarcoma	0.000966	0.000966	CcSEcCtD
Formoterol—Malaise—Doxorubicin—sarcoma	0.000959	0.000959	CcSEcCtD
Formoterol—Dry mouth—Epirubicin—sarcoma	0.000957	0.000957	CcSEcCtD
Formoterol—Palpitations—Doxorubicin—sarcoma	0.000939	0.000939	CcSEcCtD
Formoterol—Oedema—Epirubicin—sarcoma	0.000938	0.000938	CcSEcCtD
Formoterol—Anaphylactic shock—Epirubicin—sarcoma	0.000938	0.000938	CcSEcCtD
Formoterol—Infection—Epirubicin—sarcoma	0.000931	0.000931	CcSEcCtD
Formoterol—Cough—Doxorubicin—sarcoma	0.000928	0.000928	CcSEcCtD
Formoterol—Nervous system disorder—Epirubicin—sarcoma	0.000919	0.000919	CcSEcCtD
Formoterol—Hypertension—Doxorubicin—sarcoma	0.000918	0.000918	CcSEcCtD
Formoterol—Tachycardia—Epirubicin—sarcoma	0.000915	0.000915	CcSEcCtD
Formoterol—Skin disorder—Epirubicin—sarcoma	0.000911	0.000911	CcSEcCtD
Formoterol—Chest pain—Doxorubicin—sarcoma	0.000905	0.000905	CcSEcCtD
Formoterol—Arthralgia—Doxorubicin—sarcoma	0.000905	0.000905	CcSEcCtD
Formoterol—Myalgia—Doxorubicin—sarcoma	0.000905	0.000905	CcSEcCtD
Formoterol—Anxiety—Doxorubicin—sarcoma	0.000902	0.000902	CcSEcCtD
Formoterol—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—sarcoma	0.000899	0.000899	CcSEcCtD
Formoterol—Discomfort—Doxorubicin—sarcoma	0.000894	0.000894	CcSEcCtD
Formoterol—Dry mouth—Doxorubicin—sarcoma	0.000885	0.000885	CcSEcCtD
Formoterol—Hypotension—Epirubicin—sarcoma	0.000876	0.000876	CcSEcCtD
Formoterol—Anaphylactic shock—Doxorubicin—sarcoma	0.000868	0.000868	CcSEcCtD
Formoterol—Oedema—Doxorubicin—sarcoma	0.000868	0.000868	CcSEcCtD
Formoterol—Infection—Doxorubicin—sarcoma	0.000862	0.000862	CcSEcCtD
Formoterol—Musculoskeletal discomfort—Epirubicin—sarcoma	0.000854	0.000854	CcSEcCtD
Formoterol—Nervous system disorder—Doxorubicin—sarcoma	0.000851	0.000851	CcSEcCtD
Formoterol—Insomnia—Epirubicin—sarcoma	0.000848	0.000848	CcSEcCtD
Formoterol—Tachycardia—Doxorubicin—sarcoma	0.000847	0.000847	CcSEcCtD
Formoterol—Skin disorder—Doxorubicin—sarcoma	0.000843	0.000843	CcSEcCtD
Formoterol—Dyspnoea—Epirubicin—sarcoma	0.000836	0.000836	CcSEcCtD
Formoterol—Somnolence—Epirubicin—sarcoma	0.000834	0.000834	CcSEcCtD
Formoterol—Dyspepsia—Epirubicin—sarcoma	0.000825	0.000825	CcSEcCtD
Formoterol—Hypotension—Doxorubicin—sarcoma	0.000811	0.000811	CcSEcCtD
Formoterol—Gastrointestinal disorder—Epirubicin—sarcoma	0.000809	0.000809	CcSEcCtD
Formoterol—Fatigue—Epirubicin—sarcoma	0.000808	0.000808	CcSEcCtD
Formoterol—Pain—Epirubicin—sarcoma	0.000802	0.000802	CcSEcCtD
Formoterol—Constipation—Epirubicin—sarcoma	0.000802	0.000802	CcSEcCtD
Formoterol—Musculoskeletal discomfort—Doxorubicin—sarcoma	0.00079	0.00079	CcSEcCtD
Formoterol—Insomnia—Doxorubicin—sarcoma	0.000785	0.000785	CcSEcCtD
Formoterol—Dyspnoea—Doxorubicin—sarcoma	0.000773	0.000773	CcSEcCtD
Formoterol—Feeling abnormal—Epirubicin—sarcoma	0.000773	0.000773	CcSEcCtD
Formoterol—Somnolence—Doxorubicin—sarcoma	0.000771	0.000771	CcSEcCtD
Formoterol—Gastrointestinal pain—Epirubicin—sarcoma	0.000767	0.000767	CcSEcCtD
Formoterol—Dyspepsia—Doxorubicin—sarcoma	0.000764	0.000764	CcSEcCtD
Formoterol—Gastrointestinal disorder—Doxorubicin—sarcoma	0.000749	0.000749	CcSEcCtD
Formoterol—Fatigue—Doxorubicin—sarcoma	0.000748	0.000748	CcSEcCtD
Formoterol—Urticaria—Epirubicin—sarcoma	0.000745	0.000745	CcSEcCtD
Formoterol—Pain—Doxorubicin—sarcoma	0.000742	0.000742	CcSEcCtD
Formoterol—Constipation—Doxorubicin—sarcoma	0.000742	0.000742	CcSEcCtD
Formoterol—Abdominal pain—Epirubicin—sarcoma	0.000741	0.000741	CcSEcCtD
Formoterol—Body temperature increased—Epirubicin—sarcoma	0.000741	0.000741	CcSEcCtD
Formoterol—Feeling abnormal—Doxorubicin—sarcoma	0.000715	0.000715	CcSEcCtD
Formoterol—Gastrointestinal pain—Doxorubicin—sarcoma	0.000709	0.000709	CcSEcCtD
Formoterol—Hypersensitivity—Epirubicin—sarcoma	0.000691	0.000691	CcSEcCtD
Formoterol—Urticaria—Doxorubicin—sarcoma	0.000689	0.000689	CcSEcCtD
Formoterol—Abdominal pain—Doxorubicin—sarcoma	0.000686	0.000686	CcSEcCtD
Formoterol—Body temperature increased—Doxorubicin—sarcoma	0.000686	0.000686	CcSEcCtD
Formoterol—Asthenia—Epirubicin—sarcoma	0.000673	0.000673	CcSEcCtD
Formoterol—Pruritus—Epirubicin—sarcoma	0.000663	0.000663	CcSEcCtD
Formoterol—Diarrhoea—Epirubicin—sarcoma	0.000642	0.000642	CcSEcCtD
Formoterol—Hypersensitivity—Doxorubicin—sarcoma	0.000639	0.000639	CcSEcCtD
Formoterol—Asthenia—Doxorubicin—sarcoma	0.000622	0.000622	CcSEcCtD
Formoterol—Dizziness—Epirubicin—sarcoma	0.00062	0.00062	CcSEcCtD
Formoterol—Pruritus—Doxorubicin—sarcoma	0.000614	0.000614	CcSEcCtD
Formoterol—Vomiting—Epirubicin—sarcoma	0.000596	0.000596	CcSEcCtD
Formoterol—Diarrhoea—Doxorubicin—sarcoma	0.000594	0.000594	CcSEcCtD
Formoterol—Rash—Epirubicin—sarcoma	0.000591	0.000591	CcSEcCtD
Formoterol—Dermatitis—Epirubicin—sarcoma	0.000591	0.000591	CcSEcCtD
Formoterol—Headache—Epirubicin—sarcoma	0.000587	0.000587	CcSEcCtD
Formoterol—Dizziness—Doxorubicin—sarcoma	0.000574	0.000574	CcSEcCtD
Formoterol—Nausea—Epirubicin—sarcoma	0.000557	0.000557	CcSEcCtD
Formoterol—Vomiting—Doxorubicin—sarcoma	0.000552	0.000552	CcSEcCtD
Formoterol—Rash—Doxorubicin—sarcoma	0.000547	0.000547	CcSEcCtD
Formoterol—Dermatitis—Doxorubicin—sarcoma	0.000546	0.000546	CcSEcCtD
Formoterol—Headache—Doxorubicin—sarcoma	0.000543	0.000543	CcSEcCtD
Formoterol—Nausea—Doxorubicin—sarcoma	0.000515	0.000515	CcSEcCtD
